13F filing recap · Q1 2021

What did Abrams Capital Management buy in Q1 2021?

Reported stock-position changes between this filing and the previous one.

Stock value

$4.44B

Positions

Estimated turnover

10.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

CHNGChange Healthcare Inc.$274.04Mreported value+12.40M shares NUVBNuvation Bio Inc.$33.99Mreported value+3.81M shares CTLPCantaloupe Inc$22.28Mreported value+2.09M shares

Reduced positions

PCGPG&E Corp$266.34Mreported value-450.0K shares-1.9%

Exited positions

TMDXTransmedics Group, Inc.$69.65Mprior reported value-3.50M shares-100.0%BMY.RTBristol-Myers Squibb Company$17.11Mprior reported value-24.80M shares-100.0%SCUSculptor Capital Management, Inc.$7.93Mprior reported value-522.0K shares-100.0%CCOClear Channel Outdoor Holdings, Inc.$5.54Mprior reported value